Content related to Could CAR-T Version 2.0 Be on the Horizon?

The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is one of the first sites in the world to offer a promising new investigational therapy to treat

With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.

In 2018, Children’s Hospital Los Angeles was the first hospital in Southern California approved to deliver a new therapy to pediatric patients with acute lymphoblastic leukemia that did not respond to

Researchers at Children's Hospital Los Angeles have published results of this study in Lancet.

Yves De Clerck, MD

What are the advantages of immunotherapy compared to traditional cancer treatments, such as chemotherapy and radiation?

Sarah Richman, MD, PhD Cancer and Blood Disease Institute Sarah Richman, MD, PhD, investigates the use of chimeric antigen receptor (CAR) T-cell therapy for solid tumors. She and others in the field